BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30015488)

  • 1. Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium.
    Al-Awadhi FH; Gao B; Rezaei MA; Kwan JC; Li C; Ye T; Paul VJ; Luesch H
    J Med Chem; 2018 Jul; 61(14):6364-6378. PubMed ID: 30015488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis.
    Chen JC; Uang BJ; Lyu PC; Chang JY; Liu KJ; Kuo CC; Hsieh HP; Wang HC; Cheng CS; Chang YH; Chang MD; Chang WS; Lin CC
    J Med Chem; 2010 Jun; 53(11):4545-9. PubMed ID: 20481438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer.
    Al-Awadhi FH; Salvador LA; Law BK; Paul VJ; Luesch H
    Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28926939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors.
    Nam DH; Lee KS; Kim SH; Kim SM; Jung SY; Chung SH; Kim HJ; Kim ND; Jin C; Lee YS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):205-9. PubMed ID: 18024028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Amantamide, a Selective CXCR7 Agonist from Marine Cyanobacteria.
    Liang X; Luo D; Yan JL; Rezaei MA; Salvador-Reyes LA; Gunasekera SP; Li C; Ye T; Paul VJ; Luesch H
    Org Lett; 2019 Mar; 21(6):1622-1626. PubMed ID: 30779584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.
    Kowalchick JE; Leiting B; Pryor KD; Marsilio F; Wu JK; He H; Lyons KA; Eiermann GJ; Petrov A; Scapin G; Patel RA; Thornberry NA; Weber AE; Kim D
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5934-9. PubMed ID: 17827003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of tailored human caseinolytic protease P inhibitors.
    Gronauer TF; Mandl MM; Lakemeyer M; Hackl MW; Meßner M; Korotkov VS; Pachmayr J; Sieber SA
    Chem Commun (Camb); 2018 Aug; 54(70):9833-9836. PubMed ID: 30109319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: discovery, initial SAR, and molecular modeling.
    Colarusso S; Koch U; Gerlach B; Steinkühler C; De Francesco R; Altamura S; Matassa VG; Narjes F
    J Med Chem; 2003 Jan; 46(3):345-8. PubMed ID: 12540231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones.
    Murafuji H; Sugawara H; Goto M; Oyama Y; Sakai H; Imajo S; Tomoo T; Muto T
    Bioorg Med Chem; 2018 Jul; 26(12):3639-3653. PubMed ID: 29884582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases.
    Liu Y; Zhang W; Li L; Salvador LA; Chen T; Chen W; Felsenstein KM; Ladd TB; Price AR; Golde TE; He J; Xu Y; Li Y; Luesch H
    J Med Chem; 2012 Dec; 55(23):10749-65. PubMed ID: 23181502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
    Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
    Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors.
    Chen SH; Lamar J; Victor F; Snyder N; Johnson R; Heinz BA; Wakulchik M; Wang QM
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3531-6. PubMed ID: 14505664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
    Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
    Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.
    Sengupta P; Puri CS; Chokshi HA; Sheth CK; Midha AS; Chitturi TR; Thennati R; Murumkar PR; Yadav MR
    Eur J Med Chem; 2011 Nov; 46(11):5549-55. PubMed ID: 21963348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.
    Steuer C; Gege C; Fischl W; Heinonen KH; Bartenschlager R; Klein CD
    Bioorg Med Chem; 2011 Jul; 19(13):4067-74. PubMed ID: 21641807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-quantitative structure-activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors.
    Zheng X; He M; Tan X; Zheng J; Wang F; Liu S
    J Pharm Pharmacol; 2017 Sep; 69(9):1136-1144. PubMed ID: 28543088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.
    Thangavadivel S; Zelle-Rieser C; Olivier A; Postert B; Untergasser G; Kern J; Brunner A; Gunsilius E; Biedermann R; Hajek R; Pour L; Willenbacher W; Greil R; Jöhrer K
    Oncotarget; 2016 Nov; 7(48):78605-78618. PubMed ID: 27732933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway.
    Dessole G; Branca D; Ferrigno F; Kinzel O; Muraglia E; Palumbi MC; Rowley M; Serafini S; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4191-5. PubMed ID: 19540115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
    Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.